• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚甲基四氢叶酸还原酶基因多态性会改变与BRCA1相关的乳腺癌和卵巢癌风险。

Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.

作者信息

Jakubowska Anna, Gronwald Jacek, Menkiszak Janusz, Górski Bohdan, Huzarski Tomasz, Byrski Tomasz, Edler Lutz, Lubiński Jan, Scott Rodney J, Hamann Ute

机构信息

Pomeranian Medical University, ul Polabska 4, 70-111, Szczecin, Poland.

出版信息

Breast Cancer Res Treat. 2007 Sep;104(3):299-308. doi: 10.1007/s10549-006-9417-3. Epub 2006 Oct 25.

DOI:10.1007/s10549-006-9417-3
PMID:17063264
Abstract

Methylenetetrahydrofolate reductase (MTHFR), a key regulatory enzyme in the metabolism of folate, is suspected to play a role in the etiology of cancer, via its effects on DNA methylation and nucleotide synthesis. In this study we have investigated the effect of two functional polymorphisms of the MTHFR gene, MTHFR_677_C > T and MTHFR_1298_A > C, on breast and ovarian cancer risk in Polish BRCA1 mutation carriers. The study included 319 breast cancer cases, 146 ovarian cancer cases and 290 controls unaffected by breast and ovarian cancer, in situ breast cancer or any other kind of cancer. Genotyping analysis was performed using polymerase chain reaction followed by restriction fragment length polymorphism analysis. Odds ratios (OR) were calculated using univariate and multivariate logistic regression taking into account a series of confounding variables that potentially could have biased any association. The results revealed that the MTHFR_677_C > T change was associated with an increased risk of breast and ovarian cancer. The MTHFR_1298_A > C polymorphism was only associated with a decrease in breast cancer risk. Together, it appears that functional polymorphisms in the MTHFR gene modify the risk of breast and may potentially alter the risk of ovarian cancer in women with an inherited predisposition.

摘要

亚甲基四氢叶酸还原酶(MTHFR)是叶酸代谢中的关键调节酶,据怀疑它通过对DNA甲基化和核苷酸合成的影响在癌症病因学中发挥作用。在本研究中,我们调查了MTHFR基因的两种功能多态性,即MTHFR_677_C>T和MTHFR_1298_A>C,对波兰BRCA1突变携带者患乳腺癌和卵巢癌风险的影响。该研究纳入了319例乳腺癌病例、146例卵巢癌病例以及290例未患乳腺癌、卵巢癌、原位乳腺癌或任何其他类型癌症的对照。使用聚合酶链反应随后进行限制性片段长度多态性分析进行基因分型分析。考虑到一系列可能使任何关联产生偏差的混杂变量,采用单变量和多变量逻辑回归计算优势比(OR)。结果显示,MTHFR_677_C>T变化与乳腺癌和卵巢癌风险增加相关。MTHFR_1298_A>C多态性仅与乳腺癌风险降低相关。总体而言,MTHFR基因中的功能多态性似乎会改变乳腺癌风险,并且可能会改变具有遗传易感性女性患卵巢癌的风险。

相似文献

1
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.亚甲基四氢叶酸还原酶基因多态性会改变与BRCA1相关的乳腺癌和卵巢癌风险。
Breast Cancer Res Treat. 2007 Sep;104(3):299-308. doi: 10.1007/s10549-006-9417-3. Epub 2006 Oct 25.
2
Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.甲基代谢基因多态性作为意大利BRCA1/2携带者乳腺癌风险的修饰因素
Breast Cancer Res Treat. 2007 May;103(1):29-36. doi: 10.1007/s10549-006-9349-y. Epub 2006 Dec 7.
3
Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.亚甲基四氢叶酸还原酶基因的遗传多态性、血浆叶酸水平与乳腺癌易感性:台湾地区的一项病例对照研究。
Carcinogenesis. 2006 Nov;27(11):2295-300. doi: 10.1093/carcin/bgl108. Epub 2006 Jun 15.
4
Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.来自马尔默饮食与癌症队列研究的女性的叶酸摄入量、亚甲基四氢叶酸还原酶基因多态性与乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1101-10. doi: 10.1158/1055-9965.EPI-08-0401. Epub 2009 Mar 31.
5
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms.波兰的 BRCA1 相关乳腺癌和卵巢癌风险:与常见研究的多态性无关。
Breast Cancer Res Treat. 2010 Jan;119(1):201-11. doi: 10.1007/s10549-009-0390-5. Epub 2009 Apr 10.
6
One-carbon metabolism-related gene polymorphisms and risk of breast cancer.一碳代谢相关基因多态性与乳腺癌风险
Carcinogenesis. 2008 Feb;29(2):356-62. doi: 10.1093/carcin/bgm295. Epub 2008 Jan 3.
7
[MTHFR polymorphisms, dietary folate intake and risks to breast cancer].[亚甲基四氢叶酸还原酶基因多态性、膳食叶酸摄入量与乳腺癌风险]
Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jul;43(7):576-80.
8
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.亚甲基四氢叶酸还原酶(MTHFR)与乳腺癌风险:一项巢式病例对照研究及汇总荟萃分析。
Breast Cancer Res Treat. 2007 Dec;106(2):263-71. doi: 10.1007/s10549-006-9491-6. Epub 2007 Jan 27.
9
The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.RAD51基因135G>C多态性改变了波兰BRCA1突变携带者患乳腺癌和卵巢癌的风险。
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):270-5. doi: 10.1158/1055-9965.EPI-06-0562.
10
MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.亚甲基四氢叶酸还原酶基因多态性、饮食、激素替代疗法与乳腺癌风险:多民族队列研究
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2071-7.

引用本文的文献

1
Insights into genetic modifiers of breast cancer risk in carriers of BRCA1 and BRCA2 pathogenic variants.对携带BRCA1和BRCA2致病变异的乳腺癌风险基因修饰因子的见解。
Hered Cancer Clin Pract. 2025 Apr 28;23(1):15. doi: 10.1186/s13053-025-00313-y.
2
Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.亚甲基四氢叶酸还原酶基因多态性与多囊卵巢综合征和卵巢癌的风险。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20200995.
3
Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
亚甲基四氢叶酸还原酶(MTHFR)677C>T多态性与卵巢癌和宫颈癌易感性的关联:一项系统评价和荟萃分析
Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2569-2577. doi: 10.31557/APJCP.2019.20.9.2569.
4
polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls.多态性与乳腺癌、卵巢癌风险:对19260例患者和26364例对照的荟萃分析
Onco Targets Ther. 2017 Jan 6;10:227-238. doi: 10.2147/OTT.S121472. eCollection 2017.
5
Association of (C677T) Gene Polymorphism With Breast Cancer in North India.北印度地区(C677T)基因多态性与乳腺癌的关联
Biomark Cancer. 2016 Sep 27;8:111-117. doi: 10.4137/BIC.S40446. eCollection 2016.
6
Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.乳腺癌的表观遗传学:环境和生物活性食品化合物的调节作用。
Mol Nutr Food Res. 2016 Jun;60(6):1310-29. doi: 10.1002/mnfr.201501063.
7
Lack of association between MTHFR C677T polymorphism and breast cancer risk in Ahvaz, west south-Iran.伊朗西南部阿瓦士地区亚甲基四氢叶酸还原酶(MTHFR)C677T基因多态性与乳腺癌风险之间不存在关联。
Adv Biomed Res. 2016 Feb 15;5:26. doi: 10.4103/2277-9175.176352. eCollection 2016.
8
Methylenetetrahydrofolate Reductase A1298C Polymorphism and Breast Cancer Risk: A Meta-analysis of 33 Studies.亚甲基四氢叶酸还原酶A1298C多态性与乳腺癌风险:33项研究的荟萃分析
Ann Med Health Sci Res. 2014 Nov;4(6):841-51. doi: 10.4103/2141-9248.144873.
9
A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer.乳腺癌中亚甲基四氢叶酸还原酶基因多态性的基因型和单倍型的荟萃分析。
Mol Biol Rep. 2014 Sep;41(9):5775-85. doi: 10.1007/s11033-014-3450-9. Epub 2014 Jun 29.
10
The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.亚甲基四氢叶酸还原酶(MTHFR)C677T基因多态性与肿瘤风险:来自134项病例对照研究的证据。
Mol Biol Rep. 2014 Jul;41(7):4659-73. doi: 10.1007/s11033-014-3337-9. Epub 2014 Apr 18.